Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology

by Sihem Ait-Oudhia, Donald E. Mager, Robert M. Straubinger
Published 2014-03-01

Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells

by Jin Niu, Xue Wang, Jun Qu, Donald E. Mager, Robert M. Straubinger
Published 2020-10-01

Multi‐Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells

by Xu Zhu, Xiaomeng Shen, Jun Qu, Robert M. Straubinger, William J. Jusko
Published 2018-09-01

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells

by Xu Zhu, Xiaomeng Shen, Jun Qu, Jun Qu, Robert M. Straubinger, William J. Jusko
Published 2018-02-01

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients

by Sandra Roche, Fiona O’Neill, Jean Murphy, Niall Swan, Justine Meiller, Neil T. Conlon, Justin Geoghegan, Kevin Conlon, Ray McDermott, Rozana Rahman, Sinead Toomey, Ninfa L. Straubinger, Robert M. Straubinger, Robert O’Connor, Gerard McVey, Michael Moriarty, Martin Clynes
Published 2020-01-01

A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts

by Orla Coleman, Michael Henry, Fiona O'Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil T. Conlon, Justin Geoghegan, Kevin C. Conlon, Vincent Lynch, Ninfa L. Straubinger, Robert M. Straubinger, Gerard McVey, Michael Moriarty, Paula Meleady, Martin Clynes
Published 2018-11-01